Data security is crucial to us! We use the highest standards to do so! Data…
Nikolaus GascheFebruary 10, 2022
Co-founder Dr. Barbara Sladek was invited to speak about the newest trends in oncology. VIENNA,…
Barbara SladekFebruary 1, 2022
VIENNA, December 2021: For the first time in the history of the company, Biome Diagnostics…
Barbara SladekJanuary 26, 2022
VIENNA, November 2021: Biome Diagnostics, previously known as myBioma, has been mentioned as number 51…
Barbara SladekJanuary 25, 2022
VIENNA, November 2021: Co-Founder Dr. Nikolaus Gasche has been recognised as one of the top…
Barbara SladekJanuary 24, 2022
VIENNA, November 2021 The enormous burden of cancer continues to grow and its impact not…
Nikolaus GascheNovember 5, 2021
BiomeDx presents newest findings on microbiome signatures predicting immune checkpoint inhibitor therapy response. GRAZ, October…
Nikolaus GascheOctober 27, 2021
BiomeDx presents first meta-analysis for predicting immune checkpoint inhibitor therapy response. VIENNA, October 11th, 2021:…
Nikolaus GascheOctober 12, 2021
BiomeDx was invited to present its own research and discuss microbiome and nutrigenetics. September 29th,…
Nikolaus GascheSeptember 29, 2021